Federal Court’s Marijuana Ruling On Maine Licensing Rules Could Open Door To Interstate Commerce, Experts Say

Date:

A federal appellate court ruled on Wednesday that Maine’s law prohibiting non-residents from owning medical marijuana businesses in the state violates the U.S. Constitution. But legal experts say that the decision could have more far-reaching implications for interstate cannabis commerce—and could create possible complications for social equity programs.

Industry stakeholders have been closely monitoring the case, as many have argued that the Constitution’s Dormant Commerce Clause at the center of the ruling does, in fact, apply to the marijuana industry, regardless of ongoing federal cannabis prohibition.

In a 2-1 decision, the U.S. Court of Appeals for the First Circuit affirmed that interpretation, which is broadly meant to prevent states from enforcing laws that unduly restrict interstate commerce unless given specific instruction from Congress. Maine’s “residency requirement” for medical marijuana licensing is an example of an excessive regulation to that end, the panel’s majority found.

While cannabis might be federally illegal, the court said that Congress has “acknowledged the existence of a market in medical marijuana” through a spending bill rider known as the Rohrabacher–Farr amendment, which bars the Justice Department from using its funds to interfere in state-legal medical cannabis markets.

In passing that measure, and annually renewing it each year since 2014, Congress also acknowledged “that this market may continue to exist in some circumstances free from federal criminal enforcement,” the ruling says.

“Thus, whatever the circumstances may be with respect to other goods that Congress has deemed contraband, this is not a case in which Congress may be understood to have criminalized a national market with no expectation that an interstate market would continue to operate. Quite the opposite.”

Maine already dropped its residency requirement for its adult-use market following a legal challenge that was also premised on the Dormant Commerce Clause. But it sought to preserve the policy for its medical cannabis program.

Now, pending any potential appeal, out-of-state interests will be able to own and operate medical marijuana dispensaries in Maine. However, the federal court’s decision could also open the door to broader interstate cannabis commerce, as some experts believe the same rationale invalidating the residency restrictions comes into play with state-level bans on marijuana imports and exports.

Disallowing imports and exports of medical cannabis between consenting states could be construed as similarly protectionist and unconstitutional, the thinking goes.

“I think this is going to be the next shoe to drop” . “I see no way to distinguish licensing preferences from those bans on imports and exports. I think they’re equally vulnerable.”

Robert Mikos, a professor at Vanderbilt University Law School who specializes in federalism and drug policy, told Marijuana Moment on Thursday.

Of course, this appellate court ruling is limited in scope in that it currently only directly affects states within its jurisdiction, which covers Maine, Massachusetts, New Hampshire, Puerto Rico and Rhode Island. Other circuits could come to conclusions that are different from the one reached by the two-judge majority in the current case, and any potential conflict could ultimately be resolved by the Supreme Court.

Still, the ruling has caught attention outside of the small northeast pocket of the country, especially as states move to enact legislation to set the groundwork for interstate marijuana commerce.

The top marijuana regulator in California—where lawmakers are considering such legislation—reacted to the ruling by simply posting a series of eyeball emojis on Twitter.

The appellate judge’s didn’t explicitly weigh in on the idea of how state bans on cannabis imports and exports relates to the Dormant Commerce Clause, but even if the ruling does have implications to that end, it should also be pointed out that its strong emphasis on the Rohrabacher–Farr amendment would presumably mean that any further applications would be limited to medical cannabis commerce unless and until Congress enacts a similar rider covering broader adult-use programs.

In any case, Mikos and other advocates say that there’s reason to be cautious about this decision in the context of social equity programs that states have integrated into their marijuana programs.

If Maine’s residency requirement violates the Dormant Commerce Clause as an unconstitutionally protectionist policy, the same could theoretically be argued about state laws that prioritize licensing for people who have been disproportionately harmed by the drug war.

Many states that provide such licensing prioritization give cannabis business applicants more points or a head start if they live in an area within the state that has seen disparate enforcement of laws criminalizing people over marijuana.

Court decisions like this one could “put an end to a lot of social equity licensing programs because those social equity licensing programs have had to rely on the same sort of residency discrimination to work”

Mikos said

Shaleen Title, a co-founder of the Cannabis Regulators of Color Coalition (CRCC) and former Massachusetts marijuana regulator, said in a statement that the “decision, while expected, raises questions and attention to our current structure of individual state markets.”

“The takeaway from an equity perspective is that regulators and people concerned about fair markets should understand the case and be prepared for dominoes to start falling,” she said. “Being informed and prepared is the best way to counteract legal confusion and chaos that bigger companies benefit from.”

Meanwhile, not everyone necessarily agrees that the federal court ruling has broader implications for state import and export laws.

Andrew Kline, senior Counsel at the law firm Perkins Coie LLP, told Marijuana Moment that there may be other, non-protectionist reasons that states choose to ban such commerce under the status quo of federal prohibition.

“It could be protectionist—but it could also be that those state rules are in place because everyone, including state legislatures and state regulators, have been under the impression that the Controlled Substances Act prohibits interstate commerce”. “Therefore, they’re trying to sort of walk a fine line between abiding by some portion of federal law while allowing for state sales.”

Kline said

But regardless, Kline said that this decision should send a clear message to Congress that, without action on federal cannabis reform that thoughtfully accounts for the complications of interstate commerce between divergent state markets, the industry will continue to find itself grappling with issues like this Dormant Commerce Clause case.

“In some ways, this ruling is a shot across the bow for the industry. In some ways, it’s a shot in the arm,” he said. “It’s a shot across the bow because Congress has not done the work to determine which state laws should remain in place once descheduling happens, or how those state laws will be harmonized.”

“It’s a shot in the arm because the First Circuit recognized that a ‘robust’ interstate market already exists that is ‘likely to attract entrants far and wide’ and is supported by Congressional action through Rohrabacher-Farr”

Kline said

Meanwhile, state lawmakers on both coasts have been taking steps to prepare for interstate cannabis commerce while Congress stalls on ending prohibition.

For example, New Jersey Senate President Nicholas Scutari (D) filed a bill this month that would authorize the governor to enter into enter into agreements with other legal states to import and export cannabis.


Source: Marijuana Moments.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Cannabis Retailer Helped Make Christmas Merry For Kids In Need

The Christmas spirit filled the historic Stonecrest building in...

Ukraine Lawmakers Vote To Legalize Medical Cannabis

It's a new milestone for the medical cannabis industry...

Creamy Cannabis Hot Chocolate

One of the best parts of cold weather is...

What Is The Netherlands’ Trial Project Which Will Legalize All Cannabis?

On 15 December, cannabis will for the first time...